The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
The efficacy of Tenofivir to prevent perinatal transmission in chronic hepatitis B mothers'. a clinical perspective
Mubarak G1, Ferstenberg R2. Hepatology. 2018 Aug 2. doi: 10.1002/hep.30138. [Epub ahead of print]
Author information
1
State University of New York Downstate, Medical Center, Internal medicine.
2
Kings County Hospital Center, Gastroenterology SUNY Downstate Medical Center, Gastroenterology.
Abstract
With great satisfaction, we read The April, 2018 AASLD guidelines for the management of chronic hepatitis B propose that pregnant women with hepatitis B receive tenofovir in the third trimester, for viral loads greater than 200,000 International Units/ milliliter.